The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lipella Pharmaceuticals Inc.(NASDAQ:LIPO) 
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic...
Website: https://www.lipella.com
Founded: 2005
IPO Price: $5.75 (Dec 20, 2022)
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Lipella Pharmaceuticals Days Payable Outstanding ttm (DPO)
Lipella Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Lipella Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Lipella Pharmaceuticals Op Cashflow Per Share ttm
Lipella Pharmaceuticals Free Cashflow Per Share ttm
Lipella Pharmaceuticals Cash Per Share ttm
Lipella Pharmaceuticals P/S ratio ttm
Lipella Pharmaceuticals (GAAP) P/E ratio ttm
Lipella Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.